Search by Drug Name or NDC
NDC 00069-0504-30 BOSULIF 50 mg/1 Details
BOSULIF 50 mg/1
BOSULIF is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is BOSUTINIB MONOHYDRATE.
MedlinePlus Drug Summary
Bosutinib is used to treat a certain type of chronic myeloid leukemia (CML; a type of cancer of the white blood cells), including treatment in adults who have been recently found to have this condition and in those who can no longer benefit from other medications for CML or who cannot take these medications because of side effects. Bosutinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.
Related Packages: 00069-0504-30Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Bosutinib
Product Information
| NDC | 00069-0504 |
|---|---|
| Product ID | 0069-0504_291aeaa4-56f1-492a-bda9-bf98559a5c37 |
| Associated GPIs | |
| GCN Sequence Number | 085625 |
| GCN Sequence Number Description | bosutinib CAPSULE 50 MG ORAL |
| HIC3 | V1Q |
| HIC3 Description | ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS |
| GCN | 55142 |
| HICL Sequence Number | 039590 |
| HICL Sequence Number Description | BOSUTINIB |
| Brand/Generic | Brand |
| Proprietary Name | BOSULIF |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Bosutinib |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/1 |
| Substance Name | BOSUTINIB MONOHYDRATE |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Kinase Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA217729 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00069-0504-30 (00069050430)
| NDC Package Code | 0069-0504-30 |
|---|---|
| Billing NDC | 00069050430 |
| Package | 30 CAPSULE in 1 BOTTLE (0069-0504-30) |
| Marketing Start Date | 2024-01-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |